Department of Pharmaceutical Sciences, University of South Carolina, Columbia, South Carolina 29208, USA.
Protein Sci. 2011 Jan;20(1):87-94. doi: 10.1002/pro.539.
Thymidylate synthase (TS) is a well-validated cancer target that undergoes conformational switching between active and inactive states. Two mutant human TS (hTS) proteins are predicted from crystal structures to be stabilized in an inactive conformation to differing extents, with M190K populating the inactive conformation to a greater extent than A191K. Studies of intrinsic fluorescence and circular dichroism revealed that the structures of the mutants differ from those of hTS. Inclusion of the substrate dUMP was without effect on M190K but induced structural changes in A191K that are unique, relative to hTS. The effect of strong stabilization in an inactive conformation on protein phosphorylation by casein kinase 2 (CK2) was investigated. M190K was highly phosphorylated by CK2 relative to an active-stabilized mutant, R163K hTS. dUMP had no detectable effect on phosphorylation of M190K; however, dUMP inhibited phosphorylation of hTS and R163K. Studies of temperature dependence of catalysis revealed that the E(act) and temperature optimum are higher for A191K than hTS. The potency of the active-site inhibitor, raltitrexed, was lower for A191K than hTS. The response of A191K to the allosteric inhibitor, propylene diphosphonate (PDPA) was concentration dependent. Mixed inhibition was observed at low concentrations; at higher concentrations, A191K exhibited nonhyperbolic behavior with respect to dUMP and inhibition of catalysis was reversed by substrate saturation. In summary, inactive-stabilized mutants differ from hTS in thermal stability and response to substrates and PDPA. Importantly, phosphorylation of hTS by CK2 is selective for the inactive conformation, providing the first indication of physiological relevance for conformational switching.
胸苷酸合成酶(TS)是一个经过充分验证的癌症靶点,它在活性和非活性状态之间经历构象转换。从晶体结构预测,两种突变型人 TS(hTS)蛋白在不同程度上稳定存在于非活性构象中,M190K 比 A191K 更倾向于占据非活性构象。对本征荧光和圆二色性的研究表明,突变体的结构与 hTS 不同。底物 dUMP 的包含对 M190K 没有影响,但诱导 A191K 的结构变化是独特的,相对于 hTS。通过酪蛋白激酶 2(CK2)进行的强非活性构象稳定对蛋白质磷酸化的影响进行了研究。与活性稳定突变体 R163K hTS 相比,M190K 被 CK2 高度磷酸化。dUMP 对 M190K 的磷酸化没有可检测的影响;然而,dUMP 抑制 hTS 和 R163K 的磷酸化。对催化温度依赖性的研究表明,A191K 的 E(act)和温度最佳值高于 hTS。活性位点抑制剂 raltitrexed 对 A191K 的效力低于 hTS。A191K 对别构抑制剂丙二烯二磷酸(PDPA)的反应取决于浓度。在低浓度下观察到混合抑制;在较高浓度下,A191K 对 dUMP 表现出非双曲线行为,并且抑制作用被底物饱和逆转。总之,非活性稳定的突变体在热稳定性以及对底物和 PDPA 的反应方面与 hTS 不同。重要的是,CK2 对 hTS 的磷酸化选择性地针对非活性构象,为构象转换的生理相关性提供了第一个迹象。